Stay updated on A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Locations now include Louisville, Kentucky, indicating an added study site. The HHS Vulnerability Disclosure link in the footer has been removed.
    Difference
    0.2%
    Check dated 2025-12-23T22:37:02.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.3.2 appears at the top of the page, replacing v3.3.1; there are no changes to the study details or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T11:45:06.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Minor wording edits in the Publications section (the sentence about publications now states 'These publications are provided voluntarily by the person who enters information about the study and are about the results of the study.') and an update to the page revision tag (Revision: v3.3.1); no substantive study information is affected; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T11:16:44.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    A government funding status notice was removed from the page. The core study details, eligibility criteria, and contact information remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:11:25.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    No additions or deletions detected on the page; the content appears unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:48:09.000Z thumbnail image
  9. Check
    91 days ago
    Change Detected
    Summary
    - Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.
    Difference
    3%
    Check dated 2025-10-05T08:58:14.000Z thumbnail image

Stay in the know with updates to A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the A-dmDT390-bisFv & Pembrolizumab in Melanoma Clinical Trial page.